epilepsy – media

Mayo Clinic’s new mHealth app to detect Epilepsy

Mayo Clinic researchers found success with an mHealth app - EpiFinder, which can diagnose Epilepsy (A disruption in which nerve cell activity in the brain is disturbed, causing seizures). During recent research conducted at Mayo Clinic, the Epifinder app recognized epilepsy in almost 87percent of the cases.
- Source: drugdu
- 851
- May 9, 2018
epilepsy mHealth Researches
Empatica’s consumer-facing epileptic seizure-detecting wearable gets FDA clearance

Emaptica's Embrace, the consumer-facing wearable for epileptic seizure detection, received 510(k) clearance from the FDA last month. The wearable, which has already been used in clinical trials by pharma company Sunovion, has a long history that's led it up to this milestone.
- Source: MobiHealthNews
- 767
- February 6, 2018
digital health epilepsy medical device New Approvals
Neuroscientists Have Followed a Thought as it Moves Through the Brain

A study using epilepsy patients undergoing surgery has given neuroscientists an opportunity to track in unprecedented detail the movement of a thought through the human brain, all the way from inspiration to response.
- Source: Futurism
- 644
- January 26, 2018
brain epilepsy neuroscience Researches
Personalised epilepsy seizure prediction a possibility with AI

The idea of personalised seizure prediction for epilepsy is closer to becoming a reality thanks to new research published today by the University of Melbourne and IBM Research-Australia.
- Source: medicalxpress
- 662
- December 7, 2017
AI epilepsy Researches
New Drugs Could Prevent Migraine Headaches For Some People

People who experience frequent migraines may soon have access to a new class of drugs. In a pair of large studies, two drugs that tweak brain circuits involved in migraine each showed they could reduce the frequency of attacks without causing side effects, researchers report in the New England Journal of Medicine.
- Source: npr
- 521
- December 5, 2017
brain drug epilepsy Researches
FDA approves LivaNova’s VNS therapy system for epilepsy

UK-based firm LivaNova has obtained approval from the US Food and Drug Administration (FDA) for its new Vagus Nerve Stimulation (VNS) Therapy System designed to treat drug-resistant epilepsy.
- Source: medicaldevice-network
- 831
- October 12, 2017
Company Insight epilepsy New Approvals VNS

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.